News

This week in Drug Discovery Today

17 September 2019

As a service from Drug Discovery Today, we are beginning to highlight those papers that have been published as "Articles in Press" either as corrected or uncorrected proofs in the preceding week. We hope that they are of interest to you. The articles are citable via their doi.

A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome

Nasim Kiaie, Armita Mahdavi Gorabi,, Peter E.Penson, Gerald Watts, Thomas P. Johnston, Maciej Banach and Amirhossein Sahebkar

Design strategies for programmable oligonucleotide nanotherapeutics

Fitsum Feleke Sahle and Tao L. Lowe

PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges

Mohammad A. Khan, Vineet K.Jain, Md.Rizwanullah, Javed Ahmad and Keerti Jain

Nuclear G-protein-coupled receptors as putative novel pharmacological targets

Rita Ribeiro-Oliveira, Martin Vojtek, Salomé Gonçalves-Monteiro, Maria Sofia Vieira-Rocha, Joana B.Sousa, Jorge Gonçalves and Carmen Diniz

Applying drug synergy metrics to oncology combination screening data: agreements, disagreements and pitfalls

Anna H.C.Vlot, Natalia Aniceto, Michael P. Menden, Gudrun Ulrich-Merzenich and Andreas Bender

Understanding the variability of the S1′ pocket to improve matrix metalloproteinase inhibitor selectivity profiles

Aleix Gimeno, Raúl Beltrán-Debón, Miquel Mulero, Gerard Pujadas and Santiago Garcia-Vallvé

This article is featured in:
Pharmacology/ Therapeutics

Comment on this article

You must be registered and logged in to leave a comment about this article.